Remove Cardiology Remove Gene Remove Gene Editing Remove Genetics
article thumbnail

Advancing gene editing with new CRISPR/Cas9 variant

Scienmag

Using a new variant to repair DNA will improve both safety and effectiveness of the much-touted CRISPR-Cas9 tool in genetic research, Michigan Medicine researchers say. Eugene Chen, M.D., […].

article thumbnail

STAT+: Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease

STAT News

Somewhere in New Zealand, the first patient ever has been dosed with a kind of gene-editing treatment known as a base editor, a newer way of utilizing CRISPR for gene editing. The company studying the treatment, Verve Therapeutics, announced the news Tuesday. Continue to STAT+ to read the full story…